First patients test experimental cancer drug in hope for new treatment
Disease control
Completed
This was the first human study of a new experimental drug called FL115 for people with advanced solid tumors that have stopped responding to standard treatments. The main goal was to find a safe dose and understand how the body processes the drug. Researchers tested increasing do…
Phase: PHASE1 • Sponsor: Suzhou Forlong Biotechnology Co., Ltd • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC